https://www.wsj.com/articles/bausch-health-hires-advisers-amid-patent-loss-spinoff-controversy-11661201254
SVB Leerink Maintains Outperform on Lantheus Holdings, Raises Price Target to $110
SVB Leerink analyst Roanna Ruiz maintains Lantheus Holdings (NASDAQ:LNTH) with a Outperform and raises the price target from $100 to $110.